540 related articles for article (PubMed ID: 30825305)
1. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.
Andreadou I; Cabrera-Fuentes HA; Devaux Y; Frangogiannis NG; Frantz S; Guzik T; Liehn EA; Gomes CPC; Schulz R; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1117-1130. PubMed ID: 30825305
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity as a target for acute cardioprotection.
Zuurbier CJ; Abbate A; Cabrera-Fuentes HA; Cohen MV; Collino M; De Kleijn DPV; Downey JM; Pagliaro P; Preissner KT; Takahashi M; Davidson SM
Cardiovasc Res; 2019 Jun; 115(7):1131-1142. PubMed ID: 30576455
[TBL] [Abstract][Full Text] [Related]
3. Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.
Hausenloy DJ; Bøtker HE; Ferdinandy P; Heusch G; Ng GA; Redington A; Garcia-Dorado D
Cardiovasc Res; 2019 Jun; 115(7):1167-1177. PubMed ID: 30796814
[TBL] [Abstract][Full Text] [Related]
4. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.
Ong SB; Hernández-Reséndiz S; Crespo-Avilan GE; Mukhametshina RT; Kwek XY; Cabrera-Fuentes HA; Hausenloy DJ
Pharmacol Ther; 2018 Jun; 186():73-87. PubMed ID: 29330085
[TBL] [Abstract][Full Text] [Related]
5. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
[TBL] [Abstract][Full Text] [Related]
6. Cells of the Immune System in Cardiac Remodeling: Main Players in Resolution of Inflammation and Repair After Myocardial Infarction.
Kologrivova I; Shtatolkina M; Suslova T; Ryabov V
Front Immunol; 2021; 12():664457. PubMed ID: 33868315
[TBL] [Abstract][Full Text] [Related]
7. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function.
Steffens S; Van Linthout S; Sluijter JPG; Tocchetti CG; Thum T; Madonna R
Cardiovasc Res; 2020 Sep; 116(11):1850-1862. PubMed ID: 32396608
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 Inflammasome in Cardioprotective Signaling.
Zuurbier CJ
J Cardiovasc Pharmacol; 2019 Oct; 74(4):271-275. PubMed ID: 31356546
[TBL] [Abstract][Full Text] [Related]
9. Shining the spotlight on cardioprotection: beyond the cardiomyocyte.
Davidson SM; Andreadou I; Garcia-Dorado D; Hausenloy DJ
Cardiovasc Res; 2019 Jun; 115(7):1115-1116. PubMed ID: 30865272
[No Abstract] [Full Text] [Related]
10. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
[TBL] [Abstract][Full Text] [Related]
11. C-X-C Motif Chemokine Receptor 4 Blockade Promotes Tissue Repair After Myocardial Infarction by Enhancing Regulatory T Cell Mobilization and Immune-Regulatory Function.
Wang Y; Dembowsky K; Chevalier E; Stüve P; Korf-Klingebiel M; Lochner M; Napp LC; Frank H; Brinkmann E; Kanwischer A; Bauersachs J; Gyöngyösi M; Sparwasser T; Wollert KC
Circulation; 2019 Apr; 139(15):1798-1812. PubMed ID: 30696265
[TBL] [Abstract][Full Text] [Related]
12. Reducing myocardial infarct size: challenges and future opportunities.
Bulluck H; Yellon DM; Hausenloy DJ
Heart; 2016 Mar; 102(5):341-8. PubMed ID: 26674987
[TBL] [Abstract][Full Text] [Related]
13. The Role of Immune Cells in Cardiac Remodeling After Myocardial Infarction.
Zhang Y; Wen W; Liu H
J Cardiovasc Pharmacol; 2020 Oct; 76(4):407-413. PubMed ID: 33027195
[TBL] [Abstract][Full Text] [Related]
14. Selectin-targeting glycosaminoglycan-peptide conjugate limits neutrophil-mediated cardiac reperfusion injury.
Dehghani T; Thai PN; Sodhi H; Ren L; Sirish P; Nader CE; Timofeyev V; Overton JL; Li X; Lam KS; Chiamvimonvat N; Panitch A
Cardiovasc Res; 2022 Jan; 118(1):267-281. PubMed ID: 33125066
[TBL] [Abstract][Full Text] [Related]
15. The NLRP3 inflammasome in acute myocardial infarction.
Toldo S; Abbate A
Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
[TBL] [Abstract][Full Text] [Related]
16. Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.
Huang CK; Dai D; Xie H; Zhu Z; Hu J; Su M; Liu M; Lu L; Shen W; Ning G; Wang J; Zhang R; Yan X
Circ Res; 2020 Sep; 127(8):953-973. PubMed ID: 32600176
[TBL] [Abstract][Full Text] [Related]
17. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together.
Wang X; Ding Z; Yang F; Dai Y; Chen P; Theus S; Singh S; Budhiraja M; Mehta JL
Clin Sci (Lond); 2016 Aug; 130(15):1353-62. PubMed ID: 27129181
[TBL] [Abstract][Full Text] [Related]
18. Beyond Reperfusion: Acute Ventricular Unloading and Cardioprotection During Myocardial Infarction.
Curran J; Burkhoff D; Kloner RA
J Cardiovasc Transl Res; 2019 Apr; 12(2):95-106. PubMed ID: 30671717
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.
de Kleijn DPV; Chong SY; Wang X; Yatim SMJM; Fairhurst AM; Vernooij F; Zharkova O; Chan MY; Foo RSY; Timmers L; Lam CSP; Wang JW
Cardiovasc Res; 2019 Oct; 115(12):1791-1803. PubMed ID: 30830156
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
Oerlemans MI; Liu J; Arslan F; den Ouden K; van Middelaar BJ; Doevendans PA; Sluijter JP
Basic Res Cardiol; 2012 Jul; 107(4):270. PubMed ID: 22553001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
